Three different phantom TBR (3, 9 and 20) were chosen in order to reproduce the clinical range patients' tumour/background ratio (namely about 2 15).
The age ranges of patients were not consistently recorded.
See an out-of-range patient F2F, follow-up appointment.
Call an in-range patient, patient is not reached, leave a message.
Call an out-of-range patient, patient is not reached, leave a message.
See an in-range patient face-to-face(F2F), follow-up appointment.
The clinical validity will be estimated via anticoagulation control (maintenance of therapeutic range), patient satisfaction, thrombotic or haemorrhagic events and mortality.
Mean (SD) and median (range) patient delay among delayed patients was 75.8 (43.5) and 62 (181) days.
The median (range) patient age was 62 (44 75) years and 85.5% of patients were Caucasian.
The mean (range) patient's age and disease duration was 55.3 (26 68) and 17 (6–34) years, respectively.
For anticoagulation in the therapeutic range, patient's age represents an independent risk factor for bleeding with all anticoagulation modalities.
